This article has been updated to correct the name of Intrinsic's CEO.

NEW YORK (GenomeWeb) – Intrinsic LifeSciences today said it has been awarded a $4.45 million Phase II Small Business Innovation Research grant to further develop its test for the differential diagnosis of a recently discovered genetically based form of anemia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.